CJ MedTech and Pecotec Sign MOU for Next-Generation Zirconia Implant Development

CJ MedTech, a specialized company in orthopedic and dental implant research and manufacturing (CJ MedTech), announced on May 29 that it has signed a memorandum of understanding (MOU) with Pecotec, a specialist in precision semiconductor components, for the 'next-generation zirconia implant processing and outsourcing service.'

The recent signing ceremony was attended by Hyunseung Yoo, CEO of CJ MedTech, Kyungho Kim, Vice President of Pecotec, and other key executives from both companies, who discussed collaboration strategies for developing next-generation dental materials and precision manufacturing processes.

Cimedtec, a company specializing in research and manufacturing of orthopedic and dental implants, signed a memorandum of understanding (MOU) with Pecotech, a semiconductor precision parts specialist, for the "next-generation zirconia implant processing and subcontracting services." Hyunseung Yoo, CEO of Cimedtec (right), and Kyungho Kim, Vice President of Pecotech (left), are taking a commemorative photo at Cimedtec headquarters. Photo by Cimedtec

This agreement aims to secure a differentiated technological edge over conventional titanium implants by developing zirconia implants specifically designed for anterior esthetic regions. While zirconia is gaining attention for its low risk of metal allergies and its outstanding esthetics and biocompatibility, advanced processing technologies are required to achieve both high strength and precision.

Through this agreement, the two companies plan to combine CJ MedTech's ▲zirconia implant design and development capabilities ▲expertise in regulatory approval and clinical trials from the Ministry of Food and Drug Safety, with Pecotec's ▲ceramic injection molding (CIM) technology ▲ultra-precision ceramic processing technology ▲advanced material compounding technology, to develop next-generation zirconia implants.

In particular, Pecotec is a precision component specialist with 50 years of experience, currently holding the top global market share in ceramic capillaries for semiconductor packaging and TC bonding tools for high-bandwidth memory (HBM) manufacturing processes. The company possesses exceptional technological competitiveness in ultra-precision ceramic processing and micro-molding.

The two companies plan to leverage this ultra-precision manufacturing expertise from the semiconductor sector in the zirconia implant production process, increasing material efficiency compared to conventional milling, and enhancing both precision and durability for next-generation zirconia implants. In particular, by utilizing the characteristics of zirconia, which can replicate natural tooth shades, they will target the esthetically demanding anterior market segment.

Hyunseung Yoo, CEO of CJ MedTech, stated, "Zirconia implants offer excellent esthetics and biocompatibility, but require a high level of precision processing technology. Through collaboration with Pecotec, we aim to overcome the limitations of conventional ceramic processing methods and strengthen the competitiveness of next-generation zirconia implants specialized for the anterior region, accelerating our entry into the global market."

Kyungho Kim, Vice President of Pecotec, commented, "We expect meaningful synergy by combining our ultra-precision ceramic processing technology with CJ MedTech's dental clinical and product development capabilities. With this partnership, we will further expand the application of precision ceramic technology to the dental industry."

Meanwhile, CJ MedTech plans to use this collaboration as an opportunity to further advance zirconia-based precision manufacturing technology and continuously strengthen its product competitiveness in the global dental implant market.

This content was produced with the assistance of AI translation services.